C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/96 (2006.01) A61K 31/445 (2006.01) A61P 11/06 (2006.01) A61P 25/28 (2006.01) C07C 311/29 (2006.01) C07D 241/04 (2006.01) C07D 243/08 (2006.01) C07D 295/26 (2006.01) C07D 403/04 (2006.01) C07D 487/04 (2006.01)
Patent
CA 2758985
Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharma-ceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3 -mediated disorder, disease, or condition.
Linvention concerne des arylsulfonamides 2,5-disubstitués utilisés pour la modulation de l'activité de CCR3, et des compositions pharmaceutiques de ceux-ci. L'invention concerne en outre des méthodes d'utilisation des arylsulfonamides pour la prévention, le traitement ou l'amélioration d'un ou de plusieurs symptômes de troubles, maladies ou affections médiés par CCR3.
Baaum Erik Dean
Ly Tai Wei
Tran Marie Chantal Siu-Ying
Axikin Pharmaceuticals Inc.
Osler Hoskin & Harcourt Llp
LandOfFree
2,5-disubstituted arylsulfonamide ccr3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-disubstituted arylsulfonamide ccr3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-disubstituted arylsulfonamide ccr3 antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1373147